Ha B - Search Results

1

Modulation of K65R selection by zidovudine inclusion: analysis of HIV resistance selection in subjects with virologic failure receiving once-daily abacavir/lamivudine/zidovudine and tenofovir DF (study COL40263).

Ross L, Elion R, Lanier R, Dejesus E, Cohen C, Redfield RR, Gathe JC, Hsu RK, Yau L, Paulsen D, Ha B; COL40263 Study Team. Ross L, et al. Among authors: ha b. AIDS Res Hum Retroviruses. 2009 Jul;25(7):665-72. doi: 10.1089/aid.2008.0302. AIDS Res Hum Retroviruses. 2009. PMID: 19563238 Clinical Trial.

2

Once-daily abacavir/lamivudine/zidovudine plus tenofovir for the treatment of HIV-1 infection in antiretroviral-naïve subjects: a 48-week pilot study.

Elion R, Cohen C, DeJesus E, Redfield R, Gathe J, Hsu R, Yau L, Ross L, Ha B, Lanier RE, Scott T; COL40263 Study Team. Elion R, et al. Among authors: ha b. HIV Clin Trials. 2006 Nov-Dec;7(6):324-33. doi: 10.1310/hct0706-324. HIV Clin Trials. 2006. PMID: 17208898 Clinical Trial.

3

Once-daily abacavir/lamivudine and ritonavir-boosted atazanavir for the treatment of HIV-1 infection in antiretroviral-naïve patients: a 48-week pilot study.

Elion R, Dejesus E, Sension M, Berger D, Towner W, Richmond G, St Clair M, Yau L, Ha B; COL102060 Study Team. Elion R, et al. Among authors: ha b. HIV Clin Trials. 2008 May-Jun;9(3):152-63. doi: 10.1310/hct0903-152. HIV Clin Trials. 2008. PMID: 18547902 Clinical Trial.

4

Virologic response and safety of the abacavir/lamivudine fixed-dose formulation as part of highly active antiretroviral therapy: analyses of six clinical studies.

Ha B, Liao QM, Dix LP, Pappa KA. Ha B, et al. HIV Clin Trials. 2009 Mar-Apr;10(2):65-75. doi: 10.1310/hct1002-65. HIV Clin Trials. 2009. PMID: 19487176

5

Low-abundance HIV species and their impact on mutational profiles in patients with virological failure on once-daily abacavir/lamivudine/zidovudine and tenofovir.

Ross LL, Rouse E, Gerondelis P, DeJesus E, Cohen C, Horton J, Ha B, Lanier ER, Elion R; COL40263 study. Ross LL, et al. Among authors: ha b. J Antimicrob Chemother. 2010 Feb;65(2):307-15. doi: 10.1093/jac/dkp419. Epub 2009 Dec 15. J Antimicrob Chemother. 2010. PMID: 20008905 Free PMC article.

6

Simplified maintenance therapy with abacavir/lamivudine and atazanavir after discontinuation of ritonavir.

Elion R, Berger D, Richmond G, Sension M, Dejesus E, Cimoch P, St Clair M, Yau L, Ha B; Col102060 Study Team. Elion R, et al. Among authors: ha b. HIV Clin Trials. 2010 May-Jun;11(3):170-3. doi: 10.1310/hct1103-170. HIV Clin Trials. 2010. PMID: 20736153 Clinical Trial. No abstract available.

7

A pilot study of abacavir/lamivudine and raltegravir in antiretroviral-naïve HIV-1-infected patients: 48-week results of the SHIELD trial.

Young B, Vanig T, Dejesus E, Hawkins T, St Clair M, Yau L, Ha B, Shield Study Team. Young B, et al. Among authors: ha b. HIV Clin Trials. 2010 Sep-Oct;11(5):260-9. doi: 10.1310/hct1105-260. HIV Clin Trials. 2010. PMID: 21126956 Clinical Trial.

8

Efficacy and Safety of Abacavir/Lamivudine/Zidovudine Plus Tenofovir in HBV/HIV-1 Coinfected Adults: 48-Week Data.

Rodriguez AE, Dejesus E, Williams V, Irlbeck D, Ross L, Ha B, Lancaster CT. Rodriguez AE, et al. Among authors: ha b. Open AIDS J. 2010 Oct 21;4:167-70. doi: 10.2174/1874613601004010167. Open AIDS J. 2010. PMID: 21253458 Free PMC article.

9

Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results.

Kumar P, DeJesus E, Huhn G, Sloan L, Small CB, Edelstein H, Felizarta F, Hao R, Ross L, Stancil B, Pappa K, Ha B; SUPPORT Study Team. Kumar P, et al. Among authors: ha b. BMC Infect Dis. 2013 Jun 7;13:269. doi: 10.1186/1471-2334-13-269. BMC Infect Dis. 2013. PMID: 23741991 Free PMC article. Clinical Trial.

10

Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study.

Wohl DA, Arnoczy G, Fichtenbaum CJ, Campbell T, Taiwo B, Hicks C, McComsey GA, Koletar S, Sax P, Tebas P, Ha B, Massengale K, Walsh K, Stein JH. Wohl DA, et al. Among authors: ha b. Antivir Ther. 2014;19(2):141-7. doi: 10.3851/IMP2681. Epub 2013 Aug 28. Antivir Ther. 2014. PMID: 23985706 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

530 results

Search Page

Filters